Early Access Program with Arimoclomol for the Treatment of Niemann-Pick disease Type C in the US

Brief description of study

Early Access Program with Arimoclomol for the Treatment of Niemann-Pick disease Type C in the US


Clinical Study Identifier: s20-01202
ClinicalTrials.gov Identifier: NCT04316637
Principal Investigator: Nicolas Julian Abreu.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.